530119 — Natraj Proteins Income Statement
0.000.00%
- IN₹153.59m
- IN₹270.03m
- IN₹1.94bn
- 62
- 93
- 31
- 70
Annual income statement for Natraj Proteins, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,541 | 1,462 | 1,447 | 1,436 | 1,937 |
Cost of Revenue | |||||
Gross Profit | 105 | 109 | 215 | 102 | -7.31 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,502 | 1,435 | 1,309 | 1,409 | 2,035 |
Operating Profit | 38.9 | 26.8 | 138 | 26.8 | -98.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3.24 | 9.78 | 130 | 10.1 | -125 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.39 | 3.93 | 93.6 | 7.08 | -125 |
Net Income Before Extraordinary Items | |||||
Net Income | 3.39 | 3.93 | 93.6 | 7.08 | -125 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.39 | 3.93 | 93.6 | 7.08 | -125 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.904 | 1.05 | 25 | 1.89 | -33.4 |